Serious menstrual bleeding associated with use of TNF alpha blocker: two cases

dc.authorid0000-0003-1710-7018en_US
dc.authorid0000-0002-1730-2991
dc.contributor.authorBeş, Cemal
dc.contributor.authorSoy, Mehmet
dc.date.accessioned2021-06-23T19:29:31Z
dc.date.available2021-06-23T19:29:31Z
dc.date.issued2012
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractMenstrual disorders associated with the use of TNF alpha blocker have been rarely reported. Herein, we reported two cases aged 31 and 41, presenting with excessive menstrual bleeding occured after adalimumab administration which was subsequently discontinued.en_US
dc.identifier.doi10.1007/s00296-010-1455-9
dc.identifier.endpage2176en_US
dc.identifier.issn0172-8172
dc.identifier.issue7en_US
dc.identifier.pmid20352221en_US
dc.identifier.scopus2-s2.0-84863983249en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage2175en_US
dc.identifier.urihttps://doi.org/10.1007/s00296-010-1455-9
dc.identifier.urihttps://hdl.handle.net/20.500.12491/7184
dc.identifier.volume32en_US
dc.identifier.wosWOS:000305680700046en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorBeş, Cemal
dc.institutionauthorSoy, Mehmet
dc.language.isoenen_US
dc.publisherSpringer Heidelbergen_US
dc.relation.ispartofRheumatology Internationalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAdalimumaben_US
dc.subjectAnkylosing Spondylitisen_US
dc.subjectMenstrual Bleedingen_US
dc.titleSerious menstrual bleeding associated with use of TNF alpha blocker: two casesen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
cemal-bes.pdf
Boyut:
104.98 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam metin / Full Text